A detailed history of Principia Wealth Advisory, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Principia Wealth Advisory, LLC holds 3 shares of CRL stock, worth $453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 5 40.0%
Holding current value
$453
Previous $923,000 54.82%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 11, 2025

SELL
$150.52 - $190.14 $301 - $380
-2 Reduced 40.0%
3 $417,000
Q4 2024

Apr 11, 2025

BUY
$178.58 - $220.69 $892 - $1,103
5 New
5 $923,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.68B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Principia Wealth Advisory, LLC Portfolio

Follow Principia Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principia Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principia Wealth Advisory, LLC with notifications on news.